You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 16, 2025

Drug Price Trends for CLOCORTOLONE PIVALATE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CLOCORTOLONE PIVALATE

Average Pharmacy Cost for CLOCORTOLONE PIVALATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CLOCORTOLONE PIVALATE 0.1% CRM 51672-4166-06 3.98870 GM 2025-01-22
CLOCORTOLONE PIVALATE 0.1% CRM 51672-4166-06 3.38187 GM 2024-12-18
CLOCORTOLONE PIVALATE 0.1% CRM 51672-4166-06 3.36686 GM 2024-11-20
CLOCORTOLONE PIVALATE 0.1% CRM 51672-4166-06 2.99447 GM 2024-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for CLOCORTOLONE PIVALATE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CLOCORTOLONE PIVALATE 0.1% CREAM,TOP Golden State Medical Supply, Inc. 51672-4166-06 45GM 128.06 2.84578 GM 2023-06-15 - 2028-06-14 FSS
CLOCORTOLONE PIVALATE 0.1% CREAM,TOP Golden State Medical Supply, Inc. 51672-4166-06 45GM 131.12 2.91378 GM 2023-06-23 - 2028-06-14 FSS
CLOCORTOLONE PIVALATE 0.1% CREAM,TOP Golden State Medical Supply, Inc. 51672-4166-08 90GM 264.99 2.94433 GM 2023-06-15 - 2028-06-14 FSS
CLOCORTOLONE PIVALATE 0.1% CREAM,TOP Golden State Medical Supply, Inc. 51672-4166-08 90GM 271.32 3.01467 GM 2023-06-23 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Clocortolone Pivalate

Introduction to Clocortolone Pivalate

Clocortolone pivalate is a small molecule drug that targets the glucocorticoid receptor and is primarily used in the treatment of skin and musculoskeletal diseases. It is known for its anti-inflammatory and antipruritic properties, making it a versatile treatment option for various dermatoses.

Market Overview

Therapeutic Areas

Clocortolone pivalate is predominantly used in the management of skin conditions such as atopic dermatitis, eczema, psoriasis, and contact dermatitis. Its efficacy in these areas has established it as a significant player in the dermatology market[1][4].

Market Share and Competition

The topical corticosteroid market is highly competitive, with numerous products available. However, clocortolone pivalate's unique molecular structure, which includes C9 chlorination and C6 fluorination, sets it apart in terms of potency and safety profile. This differentiation helps it maintain a notable market share within the mid-potency topical corticosteroid segment[4].

Patient Satisfaction and Compliance

The drug's cosmetically elegant, moisturizing cream base enhances patient satisfaction and compliance. The availability of different dispensing systems (tubes and pumps) further tailors the treatment to individual patient needs, contributing to its market appeal[4].

Pricing and Cost Analysis

Current Pricing

As of recent data, the price of clocortolone pivalate cream 0.1% can vary depending on the pharmacy and any available discounts. For example, prices start at around $73.99 for a 45gm tube, with discounts available through programs like SingleCare, which can lower the cost to approximately $79.58[2][5].

Price Trends

Historically, the prices of topical corticosteroids have been relatively stable, with occasional fluctuations based on market dynamics and the introduction of generic versions. However, clocortolone pivalate, being a branded product with a unique formulation, tends to maintain a premium pricing strategy.

Cost Savings and Discounts

Patients can benefit from various discount programs and coupons that reduce the out-of-pocket cost. These programs are crucial in making the drug more accessible to a wider patient population[2][5].

Regulatory and Approval Status

Approval History

Clocortolone pivalate was first approved in the United States in August 1977, marking a significant milestone in its development and market entry. The approval by regulatory bodies underscores its safety and efficacy[1].

Formulary Inclusion

The drug's inclusion in formularies, such as those of the Department of Defense, indicates its acceptance and use within various healthcare systems. This inclusion helps in stabilizing its market presence and ensuring consistent demand[3].

Market Projections

Growth Potential

The demand for topical corticosteroids is expected to grow due to increasing prevalence of skin diseases and the aging population. Clocortolone pivalate, with its proven efficacy and safety profile, is well-positioned to capture a significant share of this growing market.

Competitive Landscape

While generic versions of other topical corticosteroids may enter the market, clocortolone pivalate's unique formulation and brand loyalty are likely to protect its market share. Continuous marketing and educational efforts by Promius Pharma LLC will also help in maintaining its competitive edge[4].

Economic Factors Influencing Pricing

Healthcare Policies and Reimbursement

Changes in healthcare policies and reimbursement structures can significantly impact the pricing and accessibility of clocortolone pivalate. For instance, formulary inclusions and prior authorization criteria can affect its market penetration[3].

Economic Conditions

Economic downturns or changes in consumer spending habits can influence the demand for prescription drugs, including clocortolone pivalate. However, given its essential nature in treating chronic skin conditions, the demand is likely to remain stable.

Patient and Physician Perspectives

Patient Satisfaction

Patients have shown high satisfaction with clocortolone pivalate due to its rapid onset of action, moisturizing properties, and low incidence of adverse events. This satisfaction translates into repeat prescriptions and positive word-of-mouth, supporting its market position[4].

Physician Preference

Physicians often prefer clocortolone pivalate due to its balanced potency and safety profile. The drug's versatility in treating a range of dermatoses makes it a valuable option in their treatment arsenal[4].

Conclusion

Clocortolone pivalate remains a significant player in the topical corticosteroid market, driven by its unique molecular structure, efficacy, and patient satisfaction. While pricing can fluctuate based on market dynamics and economic factors, its premium positioning and brand loyalty are expected to sustain its market share.

Key Takeaways

  • Unique Formulation: Clocortolone pivalate's distinct molecular structure enhances its potency and safety profile.
  • Market Position: It is a mid-potency topical corticosteroid with a notable market share in the dermatology segment.
  • Pricing: Prices vary but are generally stable, with discounts available through various programs.
  • Regulatory Approval: First approved in 1977, with continued inclusion in formularies.
  • Growth Potential: Expected to grow with increasing demand for topical corticosteroids.
  • Competitive Edge: Protected by brand loyalty and unique formulation.

FAQs

What is clocortolone pivalate used for?

Clocortolone pivalate is primarily used for the treatment of skin and musculoskeletal diseases, including conditions such as atopic dermatitis, eczema, psoriasis, and contact dermatitis.

Who developed clocortolone pivalate?

The originator organization of clocortolone pivalate is Promius Pharma LLC.

When was clocortolone pivalate first approved?

Clocortolone pivalate was first approved in the United States in August 1977.

What makes clocortolone pivalate unique?

Its unique molecular structure, including C9 chlorination and C6 fluorination, sets it apart in terms of potency and safety profile.

How much does clocortolone pivalate cost?

Prices start at around $73.99 for a 45gm tube, with discounts available through programs like SingleCare.

Is clocortolone pivalate available in different forms?

Yes, it is available in both tube and pump dispensing systems to cater to different patient needs.

Sources

  1. Patsnap Synapse: Unleashing the Power of Clocortolone Pivalate - A Comprehensive Review on R&D Breakthroughs.
  2. SingleCare: Clocortolone Pivalate Coupons & Prices.
  3. Department of Defense Pharmacoeconomic Center: Cumulative Minutes 2001.
  4. Practical Dermatology: Clinical Insights - Clocortolone Pivalate Cream 0.1%.
  5. GoodRx: Clocortolone Pivalate Prices, Coupons & Savings Tips.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.